Skip to content

Heart Main Vessel Angioplasty Study

A Prospective Multicenter Indian LMCA Registry - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062809
Enrollment
7500
Registered
2024-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I220- Subsequent ST elevation (STEMI) myocardial infarction of anterior wall Health Condition 2: I222- Subsequent non-ST elevation (NSTEMI) myocardial infarction Health Condition 3: I259- Chronic ischemic heart disease, unspecified

Interventions

Intervention1: Nil: NA Control Intervention1: Nil: NA

Sponsors

Interventional Cardiology Research And Training Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender aged =18years, with a diagnosis of stable ischemic heart disease (SIHD) or acute coronary syndrome (ACS) 2. PCI with single or multiple DES for the treatment of lesion located at LMCA and defined as diameter stenosis =50% by visual estimation 3. Patients willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients who have a life expectancy of less than 12 months 2. Contraindication for dual antiplatelet therapy(DAPT)

Design outcomes

Primary

MeasureTime frame
1. Procedural success 2. Rate of MACETimepoint: 1. In-hospital 2. 12 Months

Secondary

MeasureTime frame
Rate of individual MACE - cardiac death, MI, TLR, TVRTimepoint: 12 Months

Countries

India

Contacts

Public ContactDr Prathap Kumar N

Interventional Cardiology Research and Training Foundation

prathapndr@gmail.com04742721111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026